United States · 
Who invested in Amalgent Therapeutics?
Amalgent Therapeutics's investors include North Carolina Biotechnology Center.
United States · Funded startup
Who invested in Amalgent Therapeutics
Funding summaryUpdated 26 Oct 2026
$250Kraised across 1 round since 2023, from 1 source
- Latest round
- Debt, $250KFeb 2023
- Investors
- 1
The rounds
- Feb 2023
Founders and team
From the SEC filings it signed: 1 on the team.
- Malcolm A MeynExecutive Officer, Directori
On the board, as filediSam A Tetlow
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Amalgent Therapeutics
How much has Amalgent Therapeutics raised?
Amalgent Therapeutics has raised $250K across 1 round since 2023.
When did Amalgent Therapeutics last raise?
Amalgent Therapeutics's most recent round was a Debt of $250K in Feb 2023.
What was Amalgent Therapeutics's biggest round?
Its most recent round, $250K in Feb 2023, is also its largest on record.
Who backed Amalgent Therapeutics first?
Amalgent Therapeutics's first round on record, in Feb 2023, was backed by North Carolina Biotechnology Center.
What stage is Amalgent Therapeutics at?
Amalgent Therapeutics's latest named round is a Debt, in Feb 2023.
Where is Amalgent Therapeutics based?
Amalgent Therapeutics is based in the United States.
Companies like Amalgent Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.